17510631|t|Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice.
17510631|a|Increased glycogen synthase kinase-3 (GSK-3) activity is believed to contribute to the etiology of chronic disorders like Alzheimer's disease and diabetes, thus supporting therapeutic potential of GSK-3 inhibitors. However, sustained GSK-3 inhibition might induce tumorigenesis through beta-catenin-APC dysregulation. Besides, sustained in vivo inhibition by genetic means (constitutive knock-out mice) revealed unexpected embryonic lethality due to massive hepatocyte apoptosis. Here, we have generated transgenic mice with conditional (tetracycline system) expression of dominant-negative-GSK-3 as an alternative genetic approach to predict the outcome of chronic GSK-3 inhibition, either per se, or in combination with mouse models of disease. By choosing a postnatal neuron-specific promoter, here we specifically address the neurological consequences. Tet/DN-GSK-3 mice showed increased neuronal apoptosis and impaired motor coordination. Interestingly, DN-GSK-3 expression shut-down restored normal GSK-3 activity and re-established normal incidence of apoptosis and motor coordination. These results reveal the importance of intact GSK-3 activity for adult neuron viability and physiology and warn of potential neurological toxicity of GSK-3 pharmacological inhibition beyond physiological levels. Interestingly, the reversibility data also suggest that unwanted side effects are likely to revert if excessive GSK-3 inhibition is halted.
17510631	0	18	Neuronal apoptosis	Disease	MESH:D065703
17510631	34	47	motor deficit	Disease	MESH:D009461
17510631	69	74	GSK-3	Gene	56637
17510631	98	102	mice	Species	10090
17510631	114	140	glycogen synthase kinase-3	Gene	56637
17510631	142	147	GSK-3	Gene	56637
17510631	226	245	Alzheimer's disease	Disease	MESH:D000544
17510631	250	258	diabetes	Disease	MESH:D003920
17510631	301	306	GSK-3	Gene	56637
17510631	338	343	GSK-3	Gene	56637
17510631	368	381	tumorigenesis	Disease	MESH:D063646
17510631	390	402	beta-catenin	Gene	12387
17510631	403	406	APC	Gene	11789
17510631	501	505	mice	Species	10090
17510631	527	546	embryonic lethality	Disease	MESH:D020964
17510631	619	623	mice	Species	10090
17510631	642	654	tetracycline	Chemical	MESH:D013752
17510631	695	700	GSK-3	Gene	56637
17510631	770	775	GSK-3	Gene	56637
17510631	826	831	mouse	Species	10090
17510631	968	973	GSK-3	Gene	56637
17510631	974	978	mice	Species	10090
17510631	996	1014	neuronal apoptosis	Disease	MESH:D065703
17510631	1019	1046	impaired motor coordination	Disease	MESH:D001259
17510631	1066	1071	GSK-3	Gene	56637
17510631	1109	1114	GSK-3	Gene	56637
17510631	1243	1248	GSK-3	Gene	56637
17510631	1322	1343	neurological toxicity	Disease	MESH:D020258
17510631	1347	1352	GSK-3	Gene	56637
17510631	1521	1526	GSK-3	Gene	56637
17510631	Association	MESH:D001259	56637
17510631	Association	MESH:D065703	56637
17510631	Association	MESH:D003920	56637
17510631	Negative_Correlation	MESH:D020258	56637
17510631	Association	MESH:D063646	56637
17510631	Association	MESH:D000544	56637
17510631	Association	11789	12387
17510631	Association	MESH:D020964	56637
17510631	Association	MESH:D009461	56637
17510631	Negative_Correlation	12387	56637
17510631	Association	11789	56637

